Arama Sonuçları - David Valcárcel

Sonuçları Daraltın
  1. 1
    Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect

    Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect Yazar: Guillermo Ortí, Pere Barba, María Laura Fox, Olga Salamero, Francesc Bosch, David Valcárcel

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Comparison of Two Pretransplant Predictive Models and a Flexible HCT-CI Using Different Cut off Points to Determine Low-, Intermediate-, and High-Risk Groups: The Flexible HCT-CI Is the Best Predictor of NRM and OS in a Population of Patients Undergoing allo-RIC

    Comparison of Two Pretransplant Predictive Models and a Flexible HCT-CI Using Different Cut off Points to Determine Low-, Intermediate-, and High-Risk Groups: The Flexible HCT-CI I... Yazar: Pere Barba, José Luís Piñana, Rodrigo Martino, David Valcárcel, Alex Amorós, Anna Sureda, Javier Briones, Julio Delgado, Salut Brunet, Jorge Sierra

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT

    Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT Yazar: Rodrigo Martino, José Luís Piñana, Rocío Parody, David Valcárcel, Anna Sureda, Salut Brunet, Javier Briones, Julio Delgado, F Sánchez, Núria Rabella, Jorge Sierra

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease

    Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease Yazar: Irene García‐Cadenas, I Rivera, Rodrigo Martino, Albert Esquirol, Pere Barba, Silvana Novelli, Guillermo Ortí, Javier Briones, Salut Brunet, David Valcárcel, Jorge Sierra

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial

    Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial Yazar: José Antonio Pérez‐Simón, Olga López‐Villar, Enrique J. Andreu, J. Rifón, Sandra Muntión, María Díez‐Campelo, Fermín Sánchez‐Guijo, Carmen Martı́nez, David Valcárcel, Consuelo del Cañizo

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Early and Long-Term Impaired T Lymphocyte Immune Reconstitution after Cord Blood Transplantation with Antithymocyte Globulin

    Early and Long-Term Impaired T Lymphocyte Immune Reconstitution after Cord Blood Transplantation with Antithymocyte Globulin Yazar: Nerea Castillo, Irene García‐Cadenas, Pere Barba, Carme Saurina, Cristina Díaz de Heredia, Rodrigo Martino, Christelle Ferrà, Isabel Badell, Izaskun Elorza, Jorge Sierra, David Valcárcel, Sergio Querol

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Sustained response off‐treatment in eltrombopag‐treated adult patients with <scp>ITP</scp> who are refractory or relapsed after first‐line steroids: Primary, final, and ad‐hoc analyses of the Phase <scp>II TAPER</scp> trial

    Sustained response off‐treatment in eltrombopag‐treated adult patients with <scp>ITP</scp> who are refractory or relapsed after first‐line steroids: Primary, final, and ad‐hoc anal... Yazar: Nichola Cooper, Waleed Ghanima, Nicola Vianelli, David Valcárcel, İrfan Yavaşoğlu, A. L. Melikyan, Eduardo Yañez Ruiz, Jens Haenig, Olivier Somenzi, James Lee, Joan Clark, Yifan Zhang, Francesco Zaja

    Baskı/Yayın Bilgisi 2023
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation Score Allows a Better Stratification of High-Risk Patients Undergoing Reduced-Toxicity Allogeneic Hematopoietic Cell Transplantation

    Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation Score Allows a Better Stratification of High-Ris... Yazar: Pere Barba, Rodrigo Martino, José Antonio Pérez‐Simón, Francesc Fernández‐Avilés, Nerea Castillo, José Luís Piñana, Lucía López‐Anglada, Montserrat Rovira, Francesc Bosch, Enric Carreras, Lucía López‐Corral, Jorge Sierra, David Valcárcel

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft‐<i>versus</i>‐host disease after allogeneic transplantation

    Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft‐<i>versus</i>‐host disease after allogeneic transplantation Yazar: José Antonio Pérez‐Simón, María Díez‐Campelo, Rodrigo Martino, Salut Brunet, Álvaro Urbano, Marı́a Dolores Caballero, Ángel León, David Valcárcel, Enric Carreras, M.C. del Cañizo, Jesús López–Fidalgo, Jordi Sierra, Jesús F. San Miguel

    Baskı/Yayın Bilgisi 2005
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Complex, Not Monosomal, Karyotype Is the Cytogenetic Marker of Poorest Prognosis in Patients With Primary Myelodysplastic Syndrome

    Complex, Not Monosomal, Karyotype Is the Cytogenetic Marker of Poorest Prognosis in Patients With Primary Myelodysplastic Syndrome Yazar: David Valcárcel, Vera Ademà, Françesc Solé, Margarita Ortega, Benet Nomdedeu, Guillermo Sanz, Elisa Luño, Consuelo del Cañizo, Javier de la Serna, Maite Ardanaz, Víctor Marco, Rosa Collado, Javier Grau, María Julia Montoro, Mar Mallo, Teresa Vallespı́

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia

    Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia Yazar: Esperanza Such, Ulrich Germing, Luca Malcovati, José Cervera, A. Kuendgen, Matteo Giovanni Della Porta, Benet Nomdedeu, Leonor Arenillas, Elisa Luño, Blanca Xicoy, Mari Luz Amigo, David Valcárcel, Kathrin Nachtkamp, Ilaria Ambaglio, Barbara Hildebrandt, Ignacio Lorenzo, Mario Cazzola, Guillermo Sanz

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry

    Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry Yazar: Teresa Bernal, Pablo Martínez‐Camblor, Joaquín Sánchez‐Garcia, R. de Paz, Elisa Luño, Benet Nomdedeu, M. Ardanaz, Carmen Pedro, Mari Luz Amigo, Blanca Xicoy, Consuelo del Cañizo, Mar Tormo, Jürgen Floege, David Valcárcel, Salut Brunet, Luis Benlloch, Guillermo Sanz

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies

    Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hema... Yazar: Jaime Sanz, Juan Montoro, Carlos Solano, David Valcárcel, Antònia Sampol, Christelle Ferrà, Rocío Parody, Ignacio Lorenzo, Pau Montesinos, Guillermo Ortí, Juan Carlos Hernández‐Boluda, Aitana Balaguer‐Roselló, Manuel Guerreiro, Carlos Carretero, Guillermo Sanz, Miguel Á. Sanz, José Luís Piñana

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy

    Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy Yazar: Ignacio Campillo‐Marcos, Marta Casado-Peláez, Verónica Dávalos, Gerardo Ferrer, Caterina Mata, Elisabetta Mereu, Gaël Roué, David Valcárcel, Antonieta Molero, Lurdes Zamora, Blanca Xicoy, Laura Palomo, Pamela Acha, Ana Manzanares, Magnus Tobiasson, Eva Hellström‐Lindberg, Françesc Solé, Manel Esteller

    Baskı/Yayın Bilgisi 2024
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach

    Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized... Yazar: Jörg Halter, Michaël Schüpbach, Carlo Casali, Ronit Elhasid, Keith Fay, Simon Hammans, Isabel Illa, Liliane Kappeler, Stephan Krähenbühl, Thomas Lehmann, Hanna Mandel, Ramón Martí, Heinrich P. Mattle, Kim Orchard, David G. Savage, Carolyn M. Sue, David Valcárcel, Aloïs Gratwohl, Michio Hirano

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

    Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective... Yazar: Anna Sureda, Carmen Canals, R. Arranz, D. Caballero, Josep‐María Ribera, Mats Brune, Jakob Passweg, Rodrigo Martino, David Valcárcel, Juan Besalduch, Rafael F. Duarte, Antonio Léon, María Pascual, Ana García‐Noblejas, Lucía López‐Corral, Blanca Xicoy, Jorge Sierra, Norbert Schmitz

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial

    Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial Yazar: Teresa Caballero‐Velázquez, Isabel Montero, Fermín Sánchez‐Guijo, Rocío Parody, Raquel Saldaña, David Valcárcel, Oriana López‐Godino, Christelle Ferrà i Coll, Marian Cuesta, Antonio Carrillo‐Vico, Luís I. Sánchez-Abarca, Lucía López‐Corral, Francisco J. Márquez‐Malaver, José Antonio Pérez‐Simón

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Management of Adult Patients with Primary Immune Thrombocytopenia (ITP) in Clinical Practice: A Consensus Approach of the Spanish ITP Expert Group

    Management of Adult Patients with Primary Immune Thrombocytopenia (ITP) in Clinical Practice: A Consensus Approach of the Spanish ITP Expert Group Yazar: Mingot-Castellano, M. Eva, Román, M. Teresa Álvarez, Fernández Fuertes, Luis Fernando, González-López, Tomás José, Guinea de Castro, José María, Jarque, Isidro, López-Fernández, M. Fernanda, Lozano, Maria Luisa, Sánchez González, Blanca, Ferreiras, David Valcárcel, González Porras, José Ramón

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim
    Metin
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes

    Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes Yazar: Valeria Santini, David Valcárcel, Uwe Platzbecker, Rami S. Komrokji, Ann Cleverly, Michael Lahn, Jan Janssen, Yumin Zhao, Alan Y. Chiang, Aristoteles Giagounidis, Susan C. Guba, Ivelina Gueorguieva, Allicia C. Girvan, Mariana da Silva Ferreira, Tushar D. Bhagat, Kith Pradhan, Ulrich Steidl, Ashwin Sridharan, Britta Will, Amit Verma

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Pevonedistat (PEV) + Azacitidine (AZA) Versus AZA Alone As First-Line Treatment for Patients with Higher-Risk Myelodysplastic Syndromes (MDS)/Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) with 20-30% Marrow Blasts: The Randomized Phase 3 PANTHER Trial (NCT03268954)

    Pevonedistat (PEV) + Azacitidine (AZA) Versus AZA Alone As First-Line Treatment for Patients with Higher-Risk Myelodysplastic Syndromes (MDS)/Chronic Myelomonocytic Leukemia (CMML)... Yazar: Mikkael A. Sekeres, Larisa Girshova, Vadim Doronin, Maria Dıez‐Campelo, David Valcárcel, Suman Kambhampati, Nora‐Athina Viniou, Dariusz Woszczyk, Raquel De Paz Arias, Argiris Symeonidis, Αchilles Anagnostopoulos, Eduardo Munhoz, Uwe Platzbecker, Valeria Santini, Robert J. Fram, Ying Yuan, Douglas V. Faller, Lionel Adès

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: